Abstract: Power-hardware-in-the-loop (PHIL) is a form of real-time simulation that allows a real power device to interact with a simulated power system. In PHIL simulation, the power equipment under ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

People have long asked whether the world they experience is fundamentally real or the product of a simulation, a question often framed today as the simulation hypothesis. A new paper examines a ...

The simulation hypothesis—the idea that our universe might be an artificial construct running on some advanced alien computer—has long captured the public imagination. Yet most arguments about it rest ...

Recursion Pharmaceuticals, Inc. (RXRX) recently received a notable upgrade from JP Morgan analyst Eric Joseph, who shifted his rating to “Overweight” on December 17, 2025. This upgrade comes as the ...

Thomas Anderson – otherwise known as Neo – is walking up a flight of stairs when he sees a black cat shake itself and walk past a doorway. Then the moment seems to replay before his eyes. Just a touch ...

Investing personality Jim Cramer recently called Recursion Pharmaceuticals a meme stock. The facts don't back up that position, though. Recursion may not be a meme stock, but that doesn't make it a ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.

Adam is a lifelong gamer who enjoys RPGs, action adventure games and a healthy helping of VR to boot. He has written for countless sites in the gaming medium, and you can find him playing the newest ...

Recursion Pharmaceuticals stock jumped 16% on October 8, 2025, reaching around $6.08 after falling 5.4% the previous day on broader market weakness. The company reported Q2 2025 revenue of $19.2 ...